Value
—- Trailing PER (last 12 months)
- —
- EPS zero or negative; no PER
- CautionEPS zero or negative
Not applicable
TVGN
Tevogen Bio Holdings Inc.
TVGN
Tevogen Bio Holdings Inc.
$ 6.8
-
Not applicable
Insufficient data
Insufficient data
Tevogen Bio Holdings Inc. is a clinical-stage biotechnology firm dedicated to developing "off-the-shelf" precision T cell therapies for conditions across virology, oncology, and neurology. Its flagship experimental product, TVGN 489, is a precision T cell therapeutic engineered to address critical unmet needs in patients with acute-risk COVID-19, alongside a specific population experiencing long COVID. The company's operations are headquartered in Warren, New Jersey.
| Asset | Price | Div. Yield |
|---|